Endotoxemia in Critically Ill Patients with COVID-19
- 20 August 2021
- journal article
- research article
- Published by S. Karger AG in Blood Purification
- Vol. 51 (6) , 513-519
Abstract
Introduction: Mechanism(s) mediating critical illness in coronavirus disease 2019 (COVID-19) remain unclear. Previous reports demonstrate the existence of endotoxemia in viral infections without superimposed gram-negative bacteremia, but the rate and severity of endotoxemia in critically ill patients with COVID-19 requires further exploration. Materials and Methods: This is a single-center cross-sectional study of 92 intensive care unit patients diagnosed with COVID-19 pneumonia. Endotoxin activity (EA) was measured in patients that met the following criteria: (1) age ≥18 years and (2) multi-organ dysfunction score >9 from March 24, 2020, to June 20, 2020. Results: A total of 32 patients met the inclusion/exclusion criteria for measurement of EA. The median age of the study cohort was 60 years with a majority male (21/32, 65%) with hypertension (50%). A significant proportion of the patients exhibited either elevated EA in the intermediate range (0.40–0.59 EA units) (10/32, 31%) or high range (≥0.60 EA units) (14/32, 44%) or were nonresponders (NRs, low neutrophil response) to EA (6/32, 19%), with the presence of gram-negative bacteremia only in 2/32 (6%) patients. Low EA was reported in 2/32 patients. NRs (5/6, 83%) and patients with high EA (7/14, 50%) exhibited higher acute kidney injury (AKI) as compared to patients with low/intermediate EA level (1/12, 8.3%). Discussion/Conclusion: Elevated EA was observed in a large majority of critically ill patients with COVID-19 and multi-organ dysfunction despite a low incidence of concurrent gram-negative bacteremia. While we observed that elevated EA and nonresponsiveness to EA were associated with AKI in critically ill patients with COVID-19, these findings require further validation in larger longitudinal cohorts.Keywords
This publication has 25 references indexed in Scilit:
- Endotoxemia Following Multiple TraumaCritical Care Medicine, 2016
- The cytokine storm of severe influenza and development of immunomodulatory therapyCellular & Molecular Immunology, 2015
- Intestinal permeability – a new target for disease prevention and therapyBMC Gastroenterology, 2014
- Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patientsInfection, 2014
- Association between Endotoxin Activity and Acute Kidney Injury in Cardiac Patients Undergoing Cardiopulmonary BypassBlood Purification, 2014
- Bench-to-bedside review: Clinical experience with the endotoxin activity assayCritical Care, 2012
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- Early Use of Polymyxin B Hemoperfusion in Abdominal Septic ShockJAMA, 2009
- Diagnostic and Prognostic Implications of Endotoxemia in Critical Illness: Results of the MEDIC StudyThe Journal of Infectious Diseases, 2004
- Adverse Ventilatory Strategy Causes Pulmonary-to-Systemic Translocation of EndotoxinAmerican Journal of Respiratory and Critical Care Medicine, 2000